CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-19 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −1,808 | $42.39 | $77K | 166,391 |
| 2019-02-19 | ROBIN HOWARD W President & CEO | Option exercise | +33,333 | $7.21 | $240K | 350,924 |
| 2019-02-19 | ROBIN HOWARD W President & CEO | Sale | −33,333 | $42.32 | $1.4M | 317,591 |
| 2019-02-19 | ROBIN HOWARD W President & CEO | Sale | −8,882 | $42.39 | $377K | 308,709 |
| 2019-02-19 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,333 | 166,667 | ||
| 2019-02-19 | Nicholson John SVP & Chief Operating Officer | Sale | −3,822 | $42.39 | $162K | 170,655 |
| 2019-02-19 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −3,592 | $42.39 | $152K | 131,702 |
| 2019-02-19 | Hora Maninder SVP Pharma Dev & Mfg Ops | Sale | −2,386 | $42.39 | $101K | 97,143 |
| 2019-02-19 | Doberstein Stephen K SVP & Chief Scientific Officer | Sale | −3,310 | $42.39 | $140K | 99,374 |
| 2019-02-04 | Thomsen Jillian B. SVP & Chief Accounting Officer | Option exercise | +16,119 | $10.69 | $172K | 184,318 |
| 2019-02-04 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −16,119 | $42.16 | $680K | 168,199 |
| 2019-02-04 | Thomsen Jillian B. SVP & Chief Accounting Officer | Option exercise · Stock Option | −16,119 | 0 | ||
| 2019-01-28 | Nicholson John SVP & Chief Operating Officer | Option exercise | +63,000 | $10.69 | $673K | 237,477 |
| 2019-01-28 | Nicholson John SVP & Chief Operating Officer | Sale | −63,000 | $42.82 | $2.7M | 174,477 |
| 2019-01-28 | Nicholson John SVP & Chief Operating Officer | Option exercise · Stock Option | −63,000 | $10.69 | $673K | 0 |
| 2018-12-14 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award | +10,950 | 168,199 | ||
| 2018-12-14 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +22,150 | 22,150 | ||
| 2018-12-14 | ROBIN HOWARD W President & CEO | Grant or award | +68,450 | 317,591 | ||
| 2018-12-14 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +138,350 | 138,350 | ||
| 2018-12-14 | Labrucherie Gil M SVP & Chief Financial Officer | Grant or award | +28,750 | 135,294 |
Page 27 of 29 · 562 trades